Actavis Agrees To Hold Off On Generic Nuvigil
Cephalon Inc. on Tuesday dropped a patent infringement suit in Delaware against Actavis Inc. following the generic-drug maker's decision not to market a competing version of narcolepsy drug Nuvigil....To view the full article, register now.
Already a subscriber? Click here to view full article